SE7502146L - - Google Patents

Info

Publication number
SE7502146L
SE7502146L SE7502146A SE7502146A SE7502146L SE 7502146 L SE7502146 L SE 7502146L SE 7502146 A SE7502146 A SE 7502146A SE 7502146 A SE7502146 A SE 7502146A SE 7502146 L SE7502146 L SE 7502146L
Authority
SE
Sweden
Application number
SE7502146A
Other versions
SE410736B (sv
Inventor
M Riva
L Toscano
Original Assignee
Pierrel Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierrel Spa filed Critical Pierrel Spa
Publication of SE7502146L publication Critical patent/SE7502146L/xx
Publication of SE410736B publication Critical patent/SE410736B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0053—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0076—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0092—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by an OH group free esterified or etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/0026—Oxygen-containing hetero ring cyclic ketals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/0026—Oxygen-containing hetero ring cyclic ketals
    • C07J71/0031—Oxygen-containing hetero ring cyclic ketals at positions 16, 17

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE7502146A 1974-02-27 1975-02-26 Forfarande for framstellning av 2-brom-6beta-fluor-pregna-1,4-dien-3,20-dioner SE410736B (sv)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB8928/74A GB1499822A (en) 1974-02-27 1974-02-27 2-bromo-6beta-fluoropregna-1,4-diene-3,20-diones
GB2998474 1974-07-05
GB3294574 1974-07-25
GB4998274 1974-11-19

Publications (2)

Publication Number Publication Date
SE7502146L true SE7502146L (da) 1975-08-28
SE410736B SE410736B (sv) 1979-10-29

Family

ID=27447687

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7502146A SE410736B (sv) 1974-02-27 1975-02-26 Forfarande for framstellning av 2-brom-6beta-fluor-pregna-1,4-dien-3,20-dioner

Country Status (18)

Country Link
JP (1) JPS5614677B2 (da)
AR (1) AR218601A1 (da)
BE (1) BE826030A (da)
CA (1) CA1064476A (da)
CH (1) CH608243A5 (da)
DE (3) DE2508136C3 (da)
DK (1) DK144068C (da)
ES (3) ES435067A1 (da)
FI (1) FI56188C (da)
FR (1) FR2261776B1 (da)
GB (1) GB1499822A (da)
IE (1) IE42112B1 (da)
LU (1) LU71908A1 (da)
NO (1) NO144527C (da)
NZ (1) NZ176716A (da)
RO (1) RO78881A (da)
SE (1) SE410736B (da)
YU (3) YU108381A (da)

Also Published As

Publication number Publication date
NZ176716A (en) 1978-07-10
DE2533377C3 (de) 1979-08-02
RO78881A (ro) 1982-07-06
CA1064476A (en) 1979-10-16
DE2508136A1 (de) 1975-10-30
FR2261776A1 (da) 1975-09-19
IE42112L (en) 1975-08-27
DK144068B (da) 1981-11-30
DE2508136B2 (de) 1978-11-02
IE42112B1 (en) 1980-06-04
DE2533323A1 (de) 1976-02-12
BE826030A (fr) 1975-06-16
FR2261776B1 (da) 1978-07-21
NO750633L (da) 1975-08-28
SE410736B (sv) 1979-10-29
DK61575A (da) 1975-10-27
NO144527B (no) 1981-06-09
DE2533377A1 (de) 1976-02-05
DE2508136C3 (de) 1979-06-21
FI750537A (da) 1975-08-28
NO144527C (no) 1981-09-23
CH608243A5 (en) 1978-12-29
FI56188B (fi) 1979-08-31
GB1499822A (en) 1978-02-01
DK144068C (da) 1982-05-03
DE2533377B2 (de) 1978-11-16
ES435067A1 (es) 1977-07-01
ES455933A1 (es) 1978-05-01
YU108381A (en) 1982-02-28
YU108481A (en) 1982-02-28
FI56188C (fi) 1979-12-10
ES455934A1 (es) 1978-05-01
LU71908A1 (da) 1975-06-24
JPS50126652A (da) 1975-10-04
JPS5614677B2 (da) 1981-04-06
AR218601A1 (es) 1980-06-30
YU108281A (en) 1982-02-28
DE2533323C3 (de) 1979-07-12
DE2533323B2 (de) 1978-11-16

Similar Documents

Publication Publication Date Title
FR2271282A1 (da)
DK140861C (da)
FR2267472B1 (da)
FI752641A (da)
FR2263194A1 (da)
FR2294763B1 (da)
FR2262075A1 (da)
FR2295856B1 (da)
FI750827A (da)
JPS50100203U (da)
FR2262869B3 (da)
AU495920B2 (da)
FR2261776B1 (da)
AU7099174A (da)
CS172664B1 (da)
CS171471B1 (da)
BG23188A1 (da)
BG21632A1 (da)
BG21503A1 (da)
BG22732A1 (da)
BG22484A1 (da)
CH1107074A4 (da)
CH1357474A4 (da)
BG22309A1 (da)
BG22203A1 (da)